01 1BASF
01 1SODIUM IBUPROFEN DIHYDRATE
01 1Germany
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-26
Pay. Date : 2013-11-20
DMF Number : 21587
Submission : 2008-04-30
Status : Active
Type : II
20
Basf Corp, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SODIUM IBUPROFEN DIHYDRATE, with a corresponding US DMF Number 21587.
Remarkably, this DMF maintains an Active status since its submission on April 30, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 26, 2013, and payment made on November 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
